UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000013609
Receipt No. R000015895
Scientific Title Effects of eicosapentaenoic acid on left ventricular function in patients with nonischemic cardiomyopathy
Date of disclosure of the study information 2014/04/02
Last modified on 2019/04/06 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Effects of eicosapentaenoic acid on left ventricular function in patients with nonischemic cardiomyopathy
Acronym Effects of eicosapentaenoic acid to nonischemic cardiomyopathy
Scientific Title Effects of eicosapentaenoic acid on left ventricular function in patients with nonischemic cardiomyopathy
Scientific Title:Acronym Effects of eicosapentaenoic acid to nonischemic cardiomyopathy
Region
Japan

Condition
Condition chronic heart failure due to nonischemic cardiomyopathy
Classification by specialty
Cardiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To elucidate the effect of eicosapentaenoic acid in patients with chronic heart failure due to nonischemic cardiomyopathy
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes physical sign
biomarker
left ventricular function
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Dose:EPA 1800mg
Duration:6 months
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
80 years-old >
Gender Male and Female
Key inclusion criteria 1. Patients who agree a participation in this study by a document
2. Patients with chronic heart failure due to nonischemic cardiomyopathy
3. Patients who are more than 20-year-old and under 80-year-old
Key exclusion criteria 1. Patients who are bleeding
2. Patients who are pregnant or have the possibility of pregnancy
3. Patients who are seemed to be difficult to participate in this study
Target sample size 50

Research contact person
Last name of lead principal investigator
1st name
Middle name
Last name Keiichi Fukuda
Organization Keio University School of Medicine
Division name Cardiology
Zip code
Address 35 Shinanomachi Shinjuku-ku Tokyo, Japan
TEL 03-3353-1211
Email kfukuda@a2.keio.jp

Public contact
1st name of contact person
1st name
Middle name
Last name Takahiko Nishiyama
Organization Keio University School of Medicine
Division name Cardiology
Zip code
Address 35 Shinanomachi Shinjuku-ku Tokyo, Japan
TEL 03-3353-1211
Homepage URL
Email ntakahiko914@gmail.com

Sponsor
Institute Department of Cardiology, Keio University School of Medicine
Institute
Department

Funding Source
Organization Mochida pharmaceutical company
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2014 Year 04 Month 02 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Terminated
Date of protocol fixation
2012 Year 02 Month 27 Day
Date of IRB
2012 Year 02 Month 27 Day
Anticipated trial start date
2012 Year 08 Month 01 Day
Last follow-up date
2012 Year 08 Month 01 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2014 Year 04 Month 02 Day
Last modified on
2019 Year 04 Month 06 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000015895